Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Research and development

Selling and marketing

General and administrative

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Progenity

Biora Therapeutics, Inc. engages in the provision of molecular and specialized diagnostic tests to clinicians. Its products include the Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, and Resura Prenatal Test. The company was founded by Paul W. Hawran and Harry Stylli in 2010 and is headquartered in San Diego, CA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Company received more than $44 million in warrant exercises since August 2021.

Progenity Strengthens its Liquidity Position

Aspira Women’s Health 

Vinco Ventures

Camber Energy

Senseonics Holdings

Short squeeze penny stocks to watch today. The post Best Penny Stocks To Buy For A Short Squeeze?

Best Penny Stocks To Buy For A Short Squeeze? 5 To Watch Today

Digital Ally Inc

Tattooed Chef

Altimeter Growth

Huadi International Group

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) or AMC Entertainment Holdings Inc (NYSE: AMC). A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

5 Short Squeeze Candidates For The Week: AGC SPAC Rejoins, Digital Ally, Tattooed Chef Join Leaderboard

Ault Global Holdings

Phunware Inc

Here's three penny stocks to add to your watchlist right now The post Top Penny Stocks to Add to Your Watchlist in Late November appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Top Penny Stocks to Add to Your Watchlist in Late November

Greenland Technologies Holding Corporation

Thinking of investing in penny stocks? Here's three to check out The post Investing in Penny Stocks?

Investing in Penny Stocks? 3 That Could Be Worth Watching Right Now

One of the many recent IPOs since the Covid-19 pandemic, PROG stock has encountered numerous setbacks to be a comfortable ride. With their partnership with Avero Diagnotics, management is currently refocusing efforts and resources, seeking "strategic alternatives" to help the company soar.

Progenity Has Too Many Problems, Not Enough Money?

The shares of Progenity Inc (NASDAQ: PROG) increased by more than 20% pre-market today. This is why it happened.

Progenity (PROG) Stock: Why The Price Surged Today

PROG stock has had its fair share of ups and downs. With a major executive-level change, however, Progenity looked poised for progress.

4 New Patents Add to Progenity's Appeal

Shares of the biotech stock rose more than $1.50 per share Tuesday morning.

Why Progenity Stock Is Up More Than 34% Tuesday

Popular short play Progenity is enjoying a good week. PROG stock is gaining as investors continue to bet against short sellers.

PROG Stock Alert: What Is Going on With Progenity Today?

Progenity came public as a genetic testing company in 2020, then closed the lab and is doing early-stage clinical trials. The post With Progenity, What Is Pumped Will Be Dumped appeared first on InvestorPlace.

With Progenity, What Is Pumped Will Be Dumped

Matinas BioPharma Hlds

Verb Technology Company Inc

Xeris Biopharma Holdings

Penny stocks to buy right now according to analysts. The post 5 Penny Stocks To Buy According To Analysts With Targets Up To 156% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

5 Penny Stocks To Buy According To Analysts With Targets Up To 156%

The stock price of Progenity Inc (NASDAQ: PROG) increased by over 14% during intraday trading. This is why it happened.

Progenity (PROG) Stock: Why The Price Jumped Today

PROG Stock IPOed in 2020 to develop a genetic testing business. Progenity has now shut that business down, leaving shareholders in a lurch.

Progenity: Don't Bet on This Biotech Firm Yet

Kala Pharmaceuticals

SmileDirectClub

Solid Biosciences

Short squeeze penny stocks to watch right now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 5 Short Squeeze Stocks To Watch Now

Bit Digital, Inc

Synaptogenix

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE:GME) or AMC Entertainment Holdings Inc (NYSE:AMC). A short squeeze can occur when a heavily shorted stock rises in value instead of falling.

5 Short Squeeze Candidates To Watch: Huadi Tops List, Altimeter Group And Bit Digital Rejoin Leaderboard

SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference, which will be available on the conference website beginning at 10 a.m. Eastern / 7 a.m. Pacific on November 22, 2021. A link to the fireside chat will also become available at the same time in the Investors section of the company's website at progenity.com/presentations.

Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

Progressive

Only a meme stock could garner the kind of investor interest PROG stock has with no chance of returning to 2020 revenue levels anytime soon. The post I Almost Confused Progenity With Progressive Insurance appeared first on InvestorPlace.

I Almost Confused Progenity With Progressive Insurance

Progenity's plan to ditch most of its current portfolio and double down on R&D may come back to bite it later. Avoid PROG stock for now.

Progenity Is a Risky Bet Due to Its Restructuring Gamble

Progenity may be onto something big, but today it's just a meme stock. Following earnings, PROG stock is in trouble.

Say Goodbye — Not Good Buy — to the Progenity Short Squeeze

Making a penny stocks watchlist? Check these three out The post 3 ‘Must Watch' Penny Stocks in Mid-November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 ‘Must Watch' Penny Stocks in Mid-November 2021

Progenity, Inc. (PROG) CEO Adi Mohanty on Q3 2021 Results - Earnings Call Transcript

Progenity, Inc. (PROG) delivered earnings and revenue surprises of 19.15% and -98.36%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Progenity, Inc. (PROG) Reports Q3 Loss, Lags Revenue Estimates

Added important patents further protecting the company's therapeutic delivery technologies

Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the appointment of Adi Mohanty as Chief Executive Officer of the company, effective November 8, 2021. Mr. Mohanty also joins the Progenity Board of Directors.

News for Progenity Stock (PROG)